Cargando…
Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214455/ https://www.ncbi.nlm.nih.gov/pubmed/32393742 http://dx.doi.org/10.1038/s41419-020-2533-x |
| _version_ | 1783531975075692544 |
|---|---|
| author | LaCasse, Eric C. |
| author_facet | LaCasse, Eric C. |
| author_sort | LaCasse, Eric C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7214455 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72144552020-05-14 Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more? LaCasse, Eric C. Cell Death Dis Comment Nature Publishing Group UK 2020-05-11 /pmc/articles/PMC7214455/ /pubmed/32393742 http://dx.doi.org/10.1038/s41419-020-2533-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Comment LaCasse, Eric C. Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more? |
| title | Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more? |
| title_full | Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more? |
| title_fullStr | Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more? |
| title_full_unstemmed | Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more? |
| title_short | Taking aim with IAP antagonists at triple-negative breast cancer: a moving target no more? |
| title_sort | taking aim with iap antagonists at triple-negative breast cancer: a moving target no more? |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214455/ https://www.ncbi.nlm.nih.gov/pubmed/32393742 http://dx.doi.org/10.1038/s41419-020-2533-x |
| work_keys_str_mv | AT lacasseericc takingaimwithiapantagonistsattriplenegativebreastcanceramovingtargetnomore |